LIVANOVA PLC's ticker is LIVN and the CUSIP is G5509L101. A total of 215 filers reported holding LIVANOVA PLC in Q3 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,064 | +0.2% | 15,300 | -2.5% | 0.02% | +5.6% |
| Q2 2023 | $807,451 | +30.5% | 15,700 | +10.6% | 0.02% | +12.5% |
| Q1 2023 | $618,836 | +77839.0% | 14,200 | -0.7% | 0.02% | -27.3% |
| Q4 2022 | $794 | -99.9% | 14,300 | +0.7% | 0.02% | +4.8% |
| Q3 2022 | $721,000 | -15.0% | 14,200 | +1.4% | 0.02% | -8.7% |
| Q2 2022 | $848,000 | -29.6% | 14,000 | +0.7% | 0.02% | -20.7% |
| Q1 2022 | $1,204,000 | +0.5% | 13,900 | +1.5% | 0.03% | +11.5% |
| Q4 2021 | $1,198,000 | +11.2% | 13,700 | +0.7% | 0.03% | 0.0% |
| Q3 2021 | $1,077,000 | +0.8% | 13,600 | +7.1% | 0.03% | 0.0% |
| Q2 2021 | $1,068,000 | +15.0% | 12,700 | +0.8% | 0.03% | +8.3% |
| Q1 2021 | $929,000 | +16.0% | 12,600 | +4.1% | 0.02% | +4.3% |
| Q4 2020 | $801,000 | +45.1% | 12,100 | -0.8% | 0.02% | -8.0% |
| Q3 2020 | $552,000 | -5.2% | 12,200 | +0.8% | 0.02% | -28.6% |
| Q2 2020 | $582,000 | +10.0% | 12,100 | +3.4% | 0.04% | -7.9% |
| Q1 2020 | $529,000 | -40.1% | 11,700 | 0.0% | 0.04% | -13.6% |
| Q4 2019 | $883,000 | +3.2% | 11,700 | +0.9% | 0.04% | -2.2% |
| Q3 2019 | $856,000 | -5.0% | 11,600 | -6.5% | 0.04% | 0.0% |
| Q2 2019 | $901,000 | -28.7% | 12,400 | -4.6% | 0.04% | -28.6% |
| Q1 2019 | $1,264,000 | +7.1% | 13,000 | +0.8% | 0.06% | -6.0% |
| Q4 2018 | $1,180,000 | -28.4% | 12,900 | -3.0% | 0.07% | -5.6% |
| Q3 2018 | $1,649,000 | +40.0% | 13,300 | +12.7% | 0.07% | +34.0% |
| Q2 2018 | $1,178,000 | +16.7% | 11,800 | +3.5% | 0.05% | +15.2% |
| Q1 2018 | $1,009,000 | +14.8% | 11,400 | +3.6% | 0.05% | +15.0% |
| Q4 2017 | $879,000 | +8.1% | 11,000 | -5.2% | 0.04% | +5.3% |
| Q3 2017 | $813,000 | +17.5% | 11,600 | +2.7% | 0.04% | +11.8% |
| Q2 2017 | $692,000 | +29.6% | 11,300 | +3.7% | 0.03% | +25.9% |
| Q1 2017 | $534,000 | +9.9% | 10,900 | +0.9% | 0.03% | +8.0% |
| Q4 2016 | $486,000 | -29.1% | 10,800 | -5.3% | 0.02% | -30.6% |
| Q3 2016 | $685,000 | +19.5% | 11,400 | 0.0% | 0.04% | +20.0% |
| Q2 2016 | $573,000 | -10.0% | 11,400 | -3.4% | 0.03% | -9.1% |
| Q1 2016 | $637,000 | -8.3% | 11,800 | +0.9% | 0.03% | -5.7% |
| Q4 2015 | $695,000 | – | 11,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P2 Capital Partners, LLC | 850,000 | $43,155,000 | 5.33% |
| Hawk Ridge Capital Management | 1,276,955 | $64,831,000 | 4.07% |
| Paradice Investment Management LLC | 885,646 | $44,964,000 | 3.83% |
| Redmile Group, LLC | 1,536,362 | $78,001,000 | 3.03% |
| Greenlight Capital | 812,400 | $41,246,000 | 2.92% |
| Sachem Head Capital | 1,535,000 | $77,932,000 | 2.90% |
| Clearline Capital LP | 443,283 | $22,505,000 | 2.69% |
| EMINENCE CAPITAL, LP | 2,089,545 | $106,086,000 | 2.22% |
| HealthCor Management, L.P. | 328,030 | $16,654,000 | 2.08% |
| Atika Capital Management LLC | 3,831 | $19,450,000 | 1.65% |